A Randomized, Double-Blind, Placebo-Controlled, Phase 1, Dose Escalation (with optional food effect) Study of Orally Administered TRX-100 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of TRX-100 in Healthy Volunteers
100 项与 Trawsfynydd Therapeutics AU Pty Ltd. 相关的临床结果
0 项与 Trawsfynydd Therapeutics AU Pty Ltd. 相关的专利(医药)
100 项与 Trawsfynydd Therapeutics AU Pty Ltd. 相关的药物交易
100 项与 Trawsfynydd Therapeutics AU Pty Ltd. 相关的转化医学